Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How I treat Waldenström macroglobulinemia.
Dimopoulos MA, Kastritis E. Dimopoulos MA, et al. Blood. 2019 Dec 5;134(23):2022-2035. doi: 10.1182/blood.2019000725. Blood. 2019. PMID: 31527073 Free article. Review.
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).
Dimopoulos MA, García-Sanz R, Gavriatopoulou M, Morel P, Kyrtsonis MC, Michalis E, Kartasis Z, Leleu X, Palladini G, Tedeschi A, Gika D, Merlini G, Kastritis E, Sonneveld P. Dimopoulos MA, et al. Blood. 2013 Nov 7;122(19):3276-82. doi: 10.1182/blood-2013-05-503862. Epub 2013 Sep 4. Blood. 2013. PMID: 24004667 Free article. Clinical Trial.
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.
Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, García-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, Leblond V, Advani RH, Gertz MA, Kyriakou C, Thomas SK, Barlogie B, Gregory SA, Kimby E, Merlini G, Treon SP. Dimopoulos MA, et al. Blood. 2014 Aug 28;124(9):1404-11. doi: 10.1182/blood-2014-03-565135. Epub 2014 Jul 15. Blood. 2014. PMID: 25027391 Free PMC article. Review.
Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.
Kastritis E, Gavriatopoulou M, Kyrtsonis MC, Roussou M, Hadjiharissi E, Symeonidis A, Repoussis P, Michalis E, Delimpasi S, Tsatalas K, Tsirigotis P, Vassou A, Vervessou E, Katodritou E, Gika D, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Blood. 2015 Sep 10;126(11):1392-4. doi: 10.1182/blood-2015-05-647420. Blood. 2015. PMID: 26359434 Free article. Clinical Trial. No abstract available.
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia.
Leblond V, Kastritis E, Advani R, Ansell SM, Buske C, Castillo JJ, García-Sanz R, Gertz M, Kimby E, Kyriakou C, Merlini G, Minnema MC, Morel P, Morra E, Rummel M, Wechalekar A, Patterson CJ, Treon SP, Dimopoulos MA. Leblond V, et al. Among authors: dimopoulos ma. Blood. 2016 Sep 8;128(10):1321-8. doi: 10.1182/blood-2016-04-711234. Epub 2016 Jul 18. Blood. 2016. PMID: 27432877 Free article. Review.
Proteasome Inhibitors in Waldenström Macroglobulinemia.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Hematol Oncol Clin North Am. 2018 Oct;32(5):829-840. doi: 10.1016/j.hoc.2018.05.011. Epub 2018 Jul 25. Hematol Oncol Clin North Am. 2018. PMID: 30190021 Review.
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
Bagratuni T, Markou A, Patseas D, Mavrianou-Koutsoukou N, Aktypi F, Liacos CI, Sklirou AD, Theodorakakou F, Ntanasis-Stathopoulos I, Gavriatopoulou M, Trougakos IP, Lianidou E, Terpos E, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Among authors: dimopoulos ma. Blood Adv. 2022 Jan 11;6(1):189-199. doi: 10.1182/bloodadvances.2021005354. Blood Adv. 2022. PMID: 34788399 Free PMC article.
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia.
Durot E, Kanagaratnam L, Zanwar S, Toussaint E, Kastritis E, D'Sa S, Alcoceba M, Tomowiak C, Hivert B, Protin C, Abeykoon JP, Vos JMI, Michallet AS, Rodier C, Dupuis J, Leprêtre S, Merabet F, Roussel X, Zini JM, Regny C, Patel A, Morel P, Roos-Weil D, Treon SP, Dimopoulos MA, Garcia-Sanz R, Kapoor P, Castillo JJ, Delmer AJ. Durot E, et al. Among authors: dimopoulos ma. Blood Adv. 2022 Jun 28;6(12):3655-3658. doi: 10.1182/bloodadvances.2022007331. Blood Adv. 2022. PMID: 35290439 Free PMC article. No abstract available.
Angiogenesis in Waldenström's macroglobulinemia.
Terpos E, Tasidou A, Kastritis E, Eleftherakis-Papaiakovou E, Gavriatopoulou M, Migkou M, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Clin Lymphoma Myeloma. 2009 Mar;9(1):46-9. doi: 10.3816/CLM.2009.n.011. Clin Lymphoma Myeloma. 2009. PMID: 19362971 Review.
Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients.
Terpos E, Tasidou A, Eleftherakis-Papaiakovou E, Christoulas D, Gavriatopoulou M, Gkotzamanidou M, Roussou M, Kastritis E, Papadaki T, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):115-7. doi: 10.3816/CLML.2011.n.024. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21454208
1,275 results